Mouwasat Medical Services Company (TADAWUL:4002)
68.35
+0.20 (0.29%)
Apr 29, 2026, 12:54 PM AST
TADAWUL:4002 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3,223 | 2,879 | 2,706 | 2,334 | 2,144 | Upgrade
|
| Revenue Growth (YoY) | 11.92% | 6.43% | 15.91% | 8.86% | 4.85% | Upgrade
|
| Cost of Revenue | 1,880 | 1,665 | 1,411 | 1,249 | 1,163 | Upgrade
|
| Gross Profit | 1,342 | 1,214 | 1,295 | 1,085 | 981.46 | Upgrade
|
| Selling, General & Admin | 482.62 | 419.76 | 429.25 | 400.78 | 359.53 | Upgrade
|
| Other Operating Expenses | -9.29 | -7.51 | -8.38 | -6.73 | - | Upgrade
|
| Operating Expenses | 463.49 | 490.65 | 538.12 | 412.32 | 359.53 | Upgrade
|
| Operating Income | 878.76 | 723.57 | 756.56 | 672.46 | 621.93 | Upgrade
|
| Interest Expense | -19.55 | -30.46 | -46.46 | -22.88 | -8.2 | Upgrade
|
| Interest & Investment Income | 22.44 | 22.19 | 6.48 | 0.58 | 0.32 | Upgrade
|
| Earnings From Equity Investments | - | - | 10.21 | 9.88 | 10.45 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 7.71 | Upgrade
|
| EBT Excluding Unusual Items | 881.64 | 715.3 | 726.79 | 660.03 | 632.21 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -10.69 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.53 | 1.18 | 0.29 | 0.24 | -0.02 | Upgrade
|
| Pretax Income | 883.17 | 705.8 | 727.09 | 660.27 | 632.2 | Upgrade
|
| Income Tax Expense | 31.13 | 36.19 | 38.7 | 27.58 | 21.73 | Upgrade
|
| Earnings From Continuing Operations | 852.04 | 669.61 | 688.39 | 632.69 | 610.46 | Upgrade
|
| Minority Interest in Earnings | -30 | -23.85 | -30.7 | -33.38 | -32.3 | Upgrade
|
| Net Income | 822.04 | 645.76 | 657.69 | 599.31 | 578.16 | Upgrade
|
| Net Income to Common | 822.04 | 645.76 | 657.69 | 599.31 | 578.16 | Upgrade
|
| Net Income Growth | 27.30% | -1.81% | 9.74% | 3.66% | 9.47% | Upgrade
|
| Shares Outstanding (Basic) | 200 | 200 | 200 | 200 | 200 | Upgrade
|
| Shares Outstanding (Diluted) | 200 | 200 | 200 | 200 | 200 | Upgrade
|
| EPS (Basic) | 4.11 | 3.23 | 3.29 | 3.00 | 2.89 | Upgrade
|
| EPS (Diluted) | 4.11 | 3.23 | 3.29 | 3.00 | 2.89 | Upgrade
|
| EPS Growth | 27.30% | -1.81% | 9.74% | 3.66% | 9.47% | Upgrade
|
| Free Cash Flow | 768.09 | 827.41 | 536.75 | 414.52 | 355.9 | Upgrade
|
| Free Cash Flow Per Share | 3.84 | 4.14 | 2.68 | 2.07 | 1.78 | Upgrade
|
| Dividend Per Share | 2.125 | 2.000 | 1.750 | 1.500 | 1.375 | Upgrade
|
| Dividend Growth | 6.25% | 14.29% | 16.67% | 9.09% | 10.00% | Upgrade
|
| Gross Margin | 41.65% | 42.17% | 47.85% | 46.48% | 45.77% | Upgrade
|
| Operating Margin | 27.27% | 25.13% | 27.96% | 28.81% | 29.01% | Upgrade
|
| Profit Margin | 25.51% | 22.43% | 24.31% | 25.68% | 26.96% | Upgrade
|
| Free Cash Flow Margin | 23.83% | 28.74% | 19.84% | 17.76% | 16.60% | Upgrade
|
| EBITDA | 1,116 | 955.56 | 974.55 | 855.25 | 773.9 | Upgrade
|
| EBITDA Margin | 34.64% | 33.19% | 36.02% | 36.64% | 36.09% | Upgrade
|
| D&A For EBITDA | 237.49 | 231.99 | 217.99 | 182.79 | 151.97 | Upgrade
|
| EBIT | 878.76 | 723.57 | 756.56 | 672.46 | 621.93 | Upgrade
|
| EBIT Margin | 27.27% | 25.13% | 27.96% | 28.81% | 29.01% | Upgrade
|
| Effective Tax Rate | 3.52% | 5.13% | 5.32% | 4.18% | 3.44% | Upgrade
|
| Revenue as Reported | 3,223 | 2,879 | 2,706 | 2,334 | 2,144 | Upgrade
|
| Advertising Expenses | 35.92 | 31.57 | 35.17 | 28.26 | 26.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.